Ahmet Muzaffer Demir

Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial

Catherine M. Broome, Vickie McDonald, Yoshitaka Miyakawa et al. · The Lancet · 2023 · 77 citations · Full text

Thrombopoiesis, Autoimmune Disease, Blood Platelet +11

Concepts of Double Hit and Triple Hit Disease in Multiple Myeloma, Entity and Prognostic Significance

Mehmet Baysal, Ufuk Demirci, Emine İkbal Atlı et al. · Scientific Reports · 2020 · 52 citations · Full text

Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia: Effects on Epistaxis Severity Score and Quality of Life

Mehmet Baysal, Hakkı Onur Kırkızlar, Ali Caner Özdöver et al. · Turkish Journal of Hematology · 2019 · 22 citations · Full text

Frailty in patients with acute myeloid leukaemia, conceptual misapprehension of chronological age

Mehmet Baysal, Ahmet Muzaffer Demir · European Journal of Cancer Care · 2018 · 16 citations

Geriatric Psychiatry, Aging, Mixed-phenotype Acute Leukemia +20

A multi-centric study on the efficacy of eltrombopag in management of refractory chronic immune thrombocytopenia

Demet Çekdemir, Serkan Güvenç, Füsun Özdemirkıran et al. · Turkish Journal of Hematology · 2019 · 14 citations · Full text